HIF1A and cancer: Digoxin was reported to inhibit HIF-1α protein synthesis and expression of HIF-1 target genes in cancer cells, and therefore block primary tumor growth, vascularization, invasion, and metastasis (Semenza, 2012; Samanta et al., 2014).